Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Aromatic Hydrocarbon Cations: Structural Overview

Aromatic Hydrocarbon Cations: Structural Overview

Cycloheptatriene is a neutral monocyclic unsaturated hydrocarbon that consists of an odd number of carbon atoms and an intervening sp3 carbon in the ring. The three double bonds in the ring correspond to 6 π electrons, which is a Huckel number, and therefore satisfies the criteria of 4n + 2 π electrons. However, the intervening sp3 carbon disrupts the continuous overlap of p orbitals. As a result, cycloheptatriene is not aromatic.
Removing one hydrogen from the intervening CH2 group with both...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Alkenes via Reductive Coupling of Aldehydes or Ketones: McMurry Reaction

Alkenes via Reductive Coupling of Aldehydes or Ketones: McMurry Reaction

The radical dimerization of ketones or aldehydes gives vicinal diols through a pinacol coupling reaction. However, the behavior of titanium metals used for the reaction as a source of electrons is unusual. When the reaction is carried out in the presence of titanium, diols can be isolated at low temperatures. Else titanium further reacts with diols, forming alkenes through the McMurry reaction.

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCL.

Molecular therapy. Advances·2026

Same author

Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion.

Blood·2025

Same author

A spotlight on the MSc Cancer at UCL, 15 years on.

Frontiers in oncology·2025

Same author

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression.

Clinical and translational medicine·2025

Same author

Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2024

Same author

ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies.

Molecular cancer therapeutics·2024

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs.

Olivia R Allen¹, Andrew L Gott, John A Hartley

¹Department of Chemistry, University of Leeds, Leeds, UK LS2 9 JT.

Dalton Transactions (Cambridge, England : 2003)

|November 10, 2007

Summary

New ionic titanocene compounds show strong anticancer activity against various human tumors, even those resistant to cisplatin. These compounds effectively induce DNA interstrand crosslinking, a key mechanism in cancer cell death.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Experiment Videos

Last Updated: Jul 10, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Area of Science:

Organometallic Chemistry
Cancer Biology
Medicinal Chemistry

Background:

Titanocene compounds are organometallic compounds with potential therapeutic applications.
Developing novel anticancer agents effective against drug-resistant cancers is a critical unmet need.
Understanding the mechanism of action, such as DNA interaction, is crucial for drug development.

Purpose of the Study:

To synthesize and characterize novel ionic titanocene compounds.
To evaluate the in vitro cytotoxicity of these compounds against a panel of human tumor cell lines.
To investigate the DNA interstrand crosslinking activity of promising candidates.

Main Methods:

Synthesis and characterization of new ionic titanocene complexes.
In vitro cytotoxicity assays (e.g., MTT assays) on various human cancer cell lines.
DNA interstrand crosslinking assays to determine the mechanism of action.

Main Results:

Several new ionic titanocene compounds were successfully synthesized and characterized.
These compounds demonstrated significant cytotoxicity against multiple human tumor cell lines.
Notably, activity was observed against a cisplatin-resistant cell line, suggesting a different mechanism or overcoming resistance pathways.
Evidence of DNA interstrand crosslinking was established for the active compounds.

Conclusions:

Ionic titanocene compounds represent a promising class of novel anticancer agents.
Their efficacy against cisplatin-resistant cell lines warrants further investigation.
The ability to induce DNA interstrand crosslinking highlights their potential as chemotherapeutic drugs.